Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021

SELL
$77.2 - $126.54 $4.77 Million - $7.82 Million
-61,810 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$110.45 - $164.47 $375,530 - $559,198
-3,400 Reduced 5.21%
61,810 $7.01 Million
Q4 2020

Feb 09, 2021

BUY
$60.78 - $154.03 $3.96 Million - $10 Million
65,210 New
65,210 $9.58 Million

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $417M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Thornburg Investment Management Inc Portfolio

Follow Thornburg Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thornburg Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Thornburg Investment Management Inc with notifications on news.